The global TEVAR Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Type (Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm, Cerebral Aortic Aneurysm, Others), By Application (Male Patients, Female Patients).
The Thoracic Endovascular Aortic Repair (TEVAR) Market comprises endovascular devices, stent grafts, aortic stent systems, and minimally invasive technologies used in interventional cardiology, vascular surgery, and endovascular procedures for treating thoracic aortic aneurysms, aortic dissections, and aortic arch pathologies. TEVAR procedures offer aortic aneurysm repair, aortic wall reinforcement, and aortic stent graft placement through minimally invasive techniques, reducing procedural risks, recovery times, and postoperative complications compared to traditional open surgical approaches. Market dynamics include TEVAR device innovations, patient selection criteria, endovascular aortic repair outcomes, and long-term durability of thoracic stent grafts for aortic disease management.
The global TEVAR Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, TEVAR Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the TEVAR Industry include- Bolton Medical, Cardinal Health, Cook Group, Endologix, Gamida Cell, Getinge, JOTEC GmbH, Lombard Medical, Medtronic Plc, MicroPort Medical, Terumo, W.L. Gore & Associates.
The TEVAR (Thoracic Endovascular Aortic Repair) market is experiencing a trend towards a shift in preference towards minimally invasive procedures. With the aim of reducing morbidity, mortality, and hospitalization times associated with traditional open surgery for thoracic aortic diseases, there's increasing interest in endovascular techniques such as TEVAR, which offer less invasive alternatives with shorter recovery periods and fewer post-operative complications.
The primary driver for the TEVAR market is the increasing incidence of thoracic aortic diseases, including aneurysms, dissections, and traumatic injuries. Factors such as aging population, hypertension, genetic predisposition, and lifestyle habits contribute to the rising prevalence of thoracic aortic pathologies, driving the demand for effective treatment options. TEVAR offers a less invasive approach for managing these conditions, making it an attractive option for both patients and healthcare providers.
An opportunity exists in technological advancements in endovascular devices for TEVAR procedures. Companies investing in the development of innovative stent graft designs, delivery systems, and imaging technologies can address the challenges associated with TEVAR, such as precise placement, sealing of aortic lesions, and long-term durability. By offering safer, more efficient, and customizable solutions, manufacturers can capitalize on the opportunity to improve patient outcomes and expand the adoption of TEVAR as a standard of care for thoracic aortic diseases
Among the types of Thoracic Endovascular Aortic Repair (TEVAR), the treatment for Thoracic Aortic Aneurysm (TAA) is experiencing notable growth. TAA refers to an abnormal bulge in the wall of the aorta, the body's main artery supplying blood to the chest and abdomen. TEVAR involves the minimally invasive placement of a stent graft to reinforce the weakened aortic wall, reducing the risk of rupture. This procedure is particularly vital for patients diagnosed with TAA, as untreated aneurysms can lead to life-threatening complications such as aortic dissection or rupture. With advancements in medical technology and techniques, TEVAR has become the preferred treatment approach for TAA due to its lower risk profile compared to traditional open surgery and faster recovery times. The rising incidence of thoracic aortic aneurysms, coupled with increasing adoption of minimally invasive procedures, is driving the growth of TEVAR for TAA. Additionally, TEVAR's applicability to both male and female patients underscores its versatility and effectiveness in addressing this critical cardiovascular condition.
By Type
Abdominal Aortic Aneurysm
Thoracic Aortic Aneurysm
Cerebral Aortic Aneurysm
Others
By Application
Male Patients
Female Patients
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Bolton Medical
Cardinal Health
Cook Group
Endologix
Gamida Cell
Getinge
JOTEC GmbH
Lombard Medical
Medtronic Plc
MicroPort Medical
Terumo
W.L. Gore & Associates
* List not Exhaustive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the TEVAR Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the TEVAR Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 TEVAR Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global TEVAR Market Size Outlook, $ Million, 2021 to 2030
3.2 TEVAR Market Outlook by Type, $ Million, 2021 to 2030
3.3 TEVAR Market Outlook by Product, $ Million, 2021 to 2030
3.4 TEVAR Market Outlook by Application, $ Million, 2021 to 2030
3.5 TEVAR Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of TEVAR Industry
4.2 Key Market Trends in TEVAR Industry
4.3 Potential Opportunities in TEVAR Industry
4.4 Key Challenges in TEVAR Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global TEVAR Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global TEVAR Market Outlook by Segments
7.1 TEVAR Market Outlook by Segments, $ Million, 2021- 2030
By Type
Abdominal Aortic Aneurysm
Thoracic Aortic Aneurysm
Cerebral Aortic Aneurysm
Others
By Application
Male Patients
Female Patients
8 North America TEVAR Market Analysis and Outlook To 2030
8.1 Introduction to North America TEVAR Markets in 2024
8.2 North America TEVAR Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America TEVAR Market size Outlook by Segments, 2021-2030
By Type
Abdominal Aortic Aneurysm
Thoracic Aortic Aneurysm
Cerebral Aortic Aneurysm
Others
By Application
Male Patients
Female Patients
9 Europe TEVAR Market Analysis and Outlook To 2030
9.1 Introduction to Europe TEVAR Markets in 2024
9.2 Europe TEVAR Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe TEVAR Market Size Outlook by Segments, 2021-2030
By Type
Abdominal Aortic Aneurysm
Thoracic Aortic Aneurysm
Cerebral Aortic Aneurysm
Others
By Application
Male Patients
Female Patients
10 Asia Pacific TEVAR Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific TEVAR Markets in 2024
10.2 Asia Pacific TEVAR Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific TEVAR Market size Outlook by Segments, 2021-2030
By Type
Abdominal Aortic Aneurysm
Thoracic Aortic Aneurysm
Cerebral Aortic Aneurysm
Others
By Application
Male Patients
Female Patients
11 South America TEVAR Market Analysis and Outlook To 2030
11.1 Introduction to South America TEVAR Markets in 2024
11.2 South America TEVAR Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America TEVAR Market size Outlook by Segments, 2021-2030
By Type
Abdominal Aortic Aneurysm
Thoracic Aortic Aneurysm
Cerebral Aortic Aneurysm
Others
By Application
Male Patients
Female Patients
12 Middle East and Africa TEVAR Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa TEVAR Markets in 2024
12.2 Middle East and Africa TEVAR Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa TEVAR Market size Outlook by Segments, 2021-2030
By Type
Abdominal Aortic Aneurysm
Thoracic Aortic Aneurysm
Cerebral Aortic Aneurysm
Others
By Application
Male Patients
Female Patients
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Bolton Medical
Cardinal Health
Cook Group
Endologix
Gamida Cell
Getinge
JOTEC GmbH
Lombard Medical
Medtronic Plc
MicroPort Medical
Terumo
W.L. Gore & Associates
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Type
Abdominal Aortic Aneurysm
Thoracic Aortic Aneurysm
Cerebral Aortic Aneurysm
Others
By Application
Male Patients
Female Patients
The global TEVAR Market is one of the lucrative growth markets, poised to register a 7.8% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Bolton Medical, Cardinal Health, Cook Group, Endologix, Gamida Cell, Getinge, JOTEC GmbH, Lombard Medical, Medtronic Plc, MicroPort Medical, Terumo, W.L. Gore & Associates
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume